Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Light & Wonder (LNW) Completes Nasdaq Delisting as ASX CDI Listing, New ESPP and Governance Filings Go Live – 13 November 2025

Light & Wonder (LNW) Completes Nasdaq Delisting as ASX CDI Listing, New ESPP and Governance Filings Go Live – 13 November 2025

Light & Wonder, Inc. has officially wrapped up its U.S. primary listing era. The gaming and iGaming group has now completed its long‑flagged Nasdaq delisting, shifted its capital‑markets home to the Australian Securities Exchange, refreshed its employee stock purchase plan and pushed through a wave of governance and debt filings — all converging around today’s 13 November 2025 milestone. explore.investors.lnw.com+1
13 November 2025
·
John Hancock Group of Funds Adds Two Independent Trustees as Chicago’s John Hancock Prep Rallies Support for Thanksgiving ‘Harvest Havoc’ Tournament

John Hancock Group of Funds Adds Two Independent Trustees as Chicago’s John Hancock Prep Rallies Support for Thanksgiving ‘Harvest Havoc’ Tournament

The John Hancock name is in the news on two very different fronts today: on Wall Street, where the John Hancock Group of Funds has named two seasoned financial leaders as independent trustees, and on Chicago’s Southwest Side, where John Hancock College Prep is asking the community to help tip off its inaugural Thanksgiving basketball tournament.PR Newswire+1
13 November 2025
··
IRS Raises 2026 401(k) and IRA Contribution Limits: New $24,500 Cap, Higher Catch‑Ups and Roth Rules Explained

IRS Raises 2026 401(k) and IRA Contribution Limits: New $24,500 Cap, Higher Catch‑Ups and Roth Rules Explained

On Thursday, November 13, 2025, the IRS released Notice 2025‑67, confirming the official contribution limits for tax‑advantaged retirement accounts in 2026. The headline change: workers will be allowed to defer up to $24,500 into 401s and similar workplace plans next year—$1,000 more than in 2025—while the IRA limit increases to $7,500. IRS+1
13 November 2025
Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Vancouver / Jerusalem – November 13, 2025 – Shares of Clearmind Medicine Inc., a clinical‑stage psychedelic and neuroplastogen biotech company, jumped sharply on Thursday after the firm announced final approval to expand its FDA‑regulated Phase 1/2a clinical trial for Alcohol Use Disorder to Hadassah Medical Center in Jerusalem. GlobeNewswire+1
13 November 2025
··
DLocal (DLO) Stock Tumbles After Record Q3 2025 Earnings and New WhatsApp Remittance Push

DLocal (DLO) Stock Tumbles After Record Q3 2025 Earnings and New WhatsApp Remittance Push

Uruguay-based fintech DLocal Limited is having a volatile week. After closing 2.34% higher at $14.86 on Wednesday following record third‑quarter 2025 results, the stock is down around 9% on Thursday, November 13, trading near $13.5 in late-morning New York, as investors focus on margin pressure and softer economics in key markets. Parameter+1
13 November 2025
···
Canadian Solar (CSIQ) Soars as Q3 2025 Earnings Highlight Battery Storage Boom and New Mega Deals

Canadian Solar (CSIQ) Soars as Q3 2025 Earnings Highlight Battery Storage Boom and New Mega Deals

Canadian Solar Inc. lit up the solar and storage sector on Thursday after posting third‑quarter 2025 results that beat revenue and margin guidance, powered by record battery energy storage shipments and a swelling project backlog. The stock jumped more than 10–13% in pre‑market and early trading as investors cheered the strength of the company’s e‑STORAGE business and upbeat guidance for the rest of 2025 and into 2026. MarketWatch
13 November 2025
·
1 … 51 52 53 54 55 … 164

Stock Market Today

  • Revolution Medicines (RVMD) Shares Trade at a Premium Despite Robust Gains
    July 25, 2026, 2:47 PM EDT. Revolution Medicines (RVMD) shares have jumped with a 399.2% return over the past year and approximately 6.4x growth in three years, though the stock's valuation is considered steep. With a P/B ratio of 26.8x, Revolution Medicines is well above the Biotech sector's 2.5x average and peer level of 10.3x. The stock meets just 2 out of 6 valuation criteria, indicating a premium linked to its FDA-reviewed drug daraxonrasib and data from its pancreatic cancer trial, along with concerns tied to regulatory risk.